Can Chemotherapy Kill You?
Ten Scientific StudiesHere, we will consider ten scientific studies that show that chemotherapy quickly kills a certain percentage of patients who receive it. In most studies that number is in...
Ten Scientific StudiesHere, we will consider ten scientific studies that show that chemotherapy quickly kills a certain percentage of patients who receive it. In most studies that number is in...
Metronomic chemotherapy is being used in the U.S. with some preliminary success in difficult-to-treat cancers. Nick Chen, MD, Ph.D., an oncologist who serves as medical director of the Seattle...
Help Cure the Patient of CancerFirst, we must clarify the goal of any new cancer therapy. Most people would say that the goal is to help cure the patient of cancer. But a long time ago, Memorial...
Of course you know that cancer chemotherapy can make you lose your hair. Fingers and toes may become painful or numb. Your immune system, especially the white blood cells, may be destroyed. But...
Quest for Prolonging Life While chemotherapy is not particularly effective in advanced pancreatic cancer, researchers continue to try to eke out some extra months of survival for such patients...
FDA Panel Approves New Drug for Lymphoma A key panel of the Food and Drug Administration (FDA) has voted to recommend accelerated approval for the injectable drug brentuximab vedotin (Adcetris®)....
Statistical Improvement?The past 40 years have certainly seen the introduction of numerous anticancer agents for lung cancer. In the past decade and a half, the Food and Drug...
A Crucial QuestionA CTC is a ‘Circulating Tumor Cell’. There is a crucial question of whether chemotherapy can destroy CTCs. Breast cancerIn a big study of women with breast cancer, CTCs were...
Study Shows Negative Results Adding chemotherapy to radiation therapy does not prolong survival in operable, non-small-cell lung cancer, according to a large, randomized study published in the...
Not a Common View of ChemotherapySEF or Side Effect Free Chemotherapy® is a proposed treatment from Kenneth Matsumura, MD, of the Berkeley Institute International, in Berkeley, California. They...
List of AML Specialists The best way to find a specialist who treats acute myeloid leukemia (AML)—other than the time-tested method of word of mouth— is to consult the U.S.News.com website....
Many oncologists are now offering a 3-month regimen of oxaliplatin (OX) as a compromise, especially when OX is combined with oral capecitabine (Xeloda®, the oral prodrug form of 5-FU). This cuts...
Weighing the Benefits Many people criticize chemotherapy for its deficiencies. For instance, it is common knowledge that chemo can cause serious adverse effects, some of which oncologists cannot...
Long Term Treatments There is an emerging trend in oncology to keep patients on anticancer drugs for longer periods, even years at a stretch. This concept was given support from two studies...
Greater Benefit and Lower Risk The New York Times has discovered chronobiology, including chronomodulated chemotherapy. The science writer Olivia Judson, Ph.D., in the course of a column on...
Is Chemo Beneficial?In the Summer of 2001, there was an odd study of women with breast cancer who were receiving chemotherapy. They were asked whether they would still take chemotherapy even if...
The combination of trifluridine and tipiracil has been given the unusual name Lonsurf® (from Taiho Oncology). The US Food and Drug Administration (FDA) has approved a tablet combining these two...
An Outspoken CriticI read with interest a recent news report by Robert Bazell, NBC’s chief science and health correspondent. Bear in mind that Bazell has written a book on the development of the...
Protecting Patients a PriorityIn order to carry off a successful treatment, it is sometimes necessary to hospitalize the patient during the period of “pancytopenia.” This is a condition in which...
One treatment that has been used for stage IV endometrial cancer is heated intraperitoneal chemotherapy or HIPEC. According to French authors:“Seven patients are alive, four of them without...
A Problem in OncologyOne of the most fundamental and problematic issues in oncology is that of so-called surrogate markers. “Local-regional control” of a tumor is basically a “surrogate marker”...
Dr. Taofeek Owonikoko is a Professor and Vice Chair for Faculty Development in the Department of Hematology and Medical Oncology at Emory University, Atlanta. He is also a Georgia Research...
The Side Hustle A recent study provided evidence that some oncologists prescribe chemotherapy based on their financial reward rather than the medical needs of their patients. This is a...